Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Dyne Therapeutics, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A MPM BIOVENTURES 2018, L.P. reports a 9.5% stake in Dyne Therapeutics, Inc.
11/14/2022 SC 13G/A RA CAPITAL MANAGEMENT, L.P. reports a 0% stake in DYNE THERAPEUTICS, INC.
02/14/2022 SC 13G/A RA CAPITAL MANAGEMENT, L.P. reports a 5.4% stake in Dyne Therapeutics, Inc.
02/14/2022 SC 13G/A Logos Global Management LP reports a 5.7% stake in Dyne Therapeutics, Inc.
02/14/2022 SC 13G/A CITADEL ADVISORS LLC reports a 5.6% stake in Dyne Therapeutics Inc
02/11/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/16/2021 SC 13G/A CITADEL ADVISORS LLC reports a 7% stake in Dyne Therapeutics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy